Ispire Technology Inc 8-K, filed Sep 11, 2023
Ispire Technology Inc. (ISPR)
About this 8-K
Ispire Technology Inc filed this 8-K on September 11, 2023.
Items reported
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(Commission file number) | (IRS Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including
area code: (
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01 Regulation FD Disclosure.
On September 11, 2023, Ispire Technology Inc. (NASDAQ: ISPR), a Delaware corporation (the “Company”) issued a press release announcing that Michael Wang, the Co-Chief Executive Officer of the Company, and Daniel Manchock, the Chief Financial Officer of the Company will be in attendance at the H.C. Wainwright 25th Annual Global Investment Conference (the “Conference”) in New York City from September 11 to September 13, 2023, where certain presentation materials of the Company will be presented to potential investors and industry stakeholders at the Conference. A copy of such press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference. The presentation materials are being furnished with this report as Exhibit 99.2 and are incorporated herein by reference. Pursuant to the rules of the Securities and Exchange Commission, certain information contained in Item 7.01 of this report (including the Exhibit 99.2) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”), and will not be incorporated by reference into any filing by the Company under the Act or the Securities Act of 1933, as amended.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this Form 8-K:
| Exhibit No. | Description | |
| Exhibit 99.1 | Press Release, dated September 11, 2023 | |
| Exhibit 99.2 | Investor Presentation | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Ispire Technology Inc. | |||
| By: | /s/ Michael Wang | ||
| Name: | Michael Wang | ||
| Title: | Co-Chief Executive Officer | ||
| Dated: September 11, 2023 | |||
2
Exhibit 99.1
Ispire Technology Inc.’s Michael Wang and Daniel Machock to Present at H.C. Wainwright 25th Annual Global Investment Conference
New York, NY – September 11, 2023 – Ispire Technology Inc. (“Ispire” or the “Company”) (NASDAQ: ISPR), a leader in vapor technology, is pleased to announce that Co-Chief Executive Michael Wang and Chief Financial Officer Daniel Machock will be in attendance at the H.C. Wainwright 25th Annual Global Investment Conference. The conference will run from September 11 - 13, 2023, at the Lotte New York Palace Hotel in New York City.
Main Highlights
The executive team of the Company will present and engage in private 1-on-1 meetings with potential investors and industry stakeholders.
Spotlight discussions will focus on Ispire’s newly introduced technology, Ispire ONE™, designed to resolve certain major issues that the cannabis vaping industry is facing by enhancing both operational efficiency and consumer safety.
About Ispire ONE™
Ispire ONE™ technology offers:
| ● | A solution to capping issues in the manufacturing/co-packing process. |
| ● | Increased consistency and quality of filled devices. |
| ● | Prevention of leaking, spitting, or overheating in cartridges, disposables, and PODs. |
| ● | Enhanced consumer safety through sterilized factory environments. |
“We’re looking forward to introducing the potential of Ispire ONE™ to a wider array of investors at the H.C. Wainwright Conference,” said Michael Wang, the Co-Chief Executive Officer of Ispire. “We are confident that this technology offers a substantial competitive advantage in a dynamic and evolving market, aligning seamlessly with our ambitions for scaling the Ispire brand.”
Investor Engagement
The company is attracting a broad spectrum of investors, particularly those interested in innovative technologies in the consumer technology sector. Interested parties are encouraged to schedule private 1-on-1 discussions with the executive team of the Company for a deeper dive into the Company and the investment opportunities surrounding the newly introduced Ispire ONE™ technology.
About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The Company’s operating subsidiaries own or licenses from a related party more than 200 patents received or filed globally. Ispire’s tobacco products are marketed under the Aspire brand name and are sold worldwide (except in the United States, the People’s Republic of China, and Russia) primarily through our distribution network. Ispire’s cannabis products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire currently sells its cannabis vaping hardware only in the United States, and it recently commenced marketing activities in Canada and Europe, primarily in the European Union.
Please visit www.ispiretechnology.com and follow us on Facebook, Twitter, Instagram, Linkedin, Pinterest, and YouTube. Any information contained on, or that can be accessed through, the Company’s website, any other website or any social media, is not a part of this press release.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company’s business strategies, the ability of the Company to market to the Ispire ONE, Ispire ONE’s success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE and the success of their products on the markets; the Ispire ONE proving to be safe, and the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Special Note Regarding Forward-Looking Statements” and the additional risk described in Ispire’s prospectus dated April 3, 2023 filed pursuant to Rule 424(b)(1) under Securities Act (File Number: 333-269470) and in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.
Contact
For more information, kindly contact:
Investor Relations
Sherry Zheng
718.213.7386
ir@ispiretechnology.com
Exhibit 99.2
M anagement Presentation September 2023 Ispire Technology Inc. (NASDAQ : ISPR)
Disclaimer 1 Source: US Tiger research This presentation (this “Presentation”) has been prepared by Ispire Technology Inc . (the “Company”) solely for informational purposes . The information included herein in this Presentation has not been independently verified . No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers or representatives or the underwriters as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or opinions presented or contained in this presentation . By viewing or accessing the information contained in this Presentation, you acknowledge and agree that none of the Company or any of its affiliates, advisers or representatives or the underwriters accept any responsibility whatsoever (in negligence or otherwise) for any loss howsoever arising from any information presented or contained in this Presentation or otherwise arising in connection with this Presentation . The information presented or contained in this Presentation is subject to change without notice and its accuracy is not guaranteed . None of the Company or any of its affiliates, advisers or representatives or the underwriters make any undertaking to update any such information subsequent to the date hereof except as required by law . This Presentation should not be construed as legal, tax, investment or other advice . The Company filed a registration statement on Form S - 1 with the U . S . Securities and Exchange Commission (the “SEC”), as well as other documents and any amendments or supplements thereto filed with the SEC, File No . 333 — 269470 (the “Registration Statement”), relating to its initial public offering of its securities in the United States, and the Registration Statement was declared effective by the SEC on April 3 , 2023 . The offering of the Company’s securities made in the United States was made solely on the basis of the prospectus included in the Registration Statement . Any decision to purchase the Company’s securities in any offering should be made solely on the basis of the information contained in the prospectus included in the Registration Statement . This Presentation contains statements that reflect the Company’s intent, beliefs or current expectations about the future These statements can be recognized by the use of words such as “ expects,”“ plans,” “will,” “estimates,” “projects,” “intends” or words of similar meaning, but the absence of these words does not mean that a statement is not forward - looking . These forward - looking statements are made only, and are based on, estimates and information available to the Company, as of the date of this Presentation, and are not guarantees of future performance . All statements other than statements of historical fact in this Presentation are forward - looking statements, including but not limited to, the Company’s goals and growth strategies ; the Company’s expectations regarding demand for and market acceptance of the Company’s brand and platforms ; the Company’s future business development, results of operations and financial condition ; the Company’s ability to establish manufacturing operations in Vietnam and the United States ; the Company’s ability to establish relationships with suppliers other than Shenzhen Yi Jia ; the effect of regulations relating to the marketing and sale of vaping products in the United States and other countries ; the Company’s ability to maintain and improve the Company’s infrastructure necessary to operate the Company’s business ; competition in the vaping industry ; the expected growth of, and trends in, the markets for the Company’s products and services in the markets in which jurisdictions that we sell the Company’s products ; the development of a market for cannabis vaping products outside of the United States, including the legalization of cannabis in certain European countries ; the expected growth of, and trends in, the markets for the Company’s products and services in the markets in which jurisdictions that we sell the Company’s products ; the effect of supply chain issues on the Company’s ability to manufacture and the Company’s ability and the ability of the Company’s distributors to distribute product ; the development of a market for cannabis vaping product and the Company’s ability to market cannabis products to adult users ; the Company’s ability to compete successfully for both tobacco and cannabis products, the expected growth of, and trends in, the markets for the Company’s products and services jurisdictions that we sell or plan to sell the Company’s products ; effects of the COVID - 19 pandemic and steps taken by governments to address the pandemic and the effect of the COVID - 19 pandemic on the Company’s supply chain ; government policies and regulations relating to the Company’s operations, including regulations relating to the sale and distribution of the Company’s vaping products and those relating to manufacturing operations ; the Company’s ability to develop and maintain effective disclosure controls and internal controls over financial reporting ; the Company’s ability to use of proceeds from its initial public offering in the manner contemplated by the Company ; the effect of any sales or the anticipation of sales by the selling stockholders upon the market price of the Company’s common stock ; the Company’s ability to meet the continued listing requirement on the Nasdaq Stock Market ; general economic and business condition in China and elsewhere ; the Company's ability to operate as a public company ; the period of time for which its current liquidity will enable the Company to fund its operations ; general economic and business conditions ; the volatility of the Company's operating results and financial condition and the price of its common stock ; the Company's ability to attract and retain qualified senior management personnel and research and development staff ; and assumptions underlying or related to any of the foregoing and other risks detailed in the Company's filings with the SEC, including the Registration Statement, and available on the SEC’s website at http : //www . sec . gov .
Disclaimer (Cont’d) 2 Source: US Tiger research These forward - looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the Company and the industry . The Company undertakes no obligation to update forward - looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law . Although the Company believes that the expectations expressed in these forward - looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results . This Presentation does not constitute an offer to sell or an invitation to purchase or subscribe for any securities of the Company for sale in the United States or anywhere else . No part of this Presentation shall form the basis of or be relied upon in connection with any contract or commitment whatsoever . Specifically, these materials do not constitute a “prospectus” within the meaning of the US Securities Act of 1933 , as amended, and the regulations enacted thereunder . This Presentation does not contain all relevant information relating to the Company or its securities, particularly with respect to the risks and special considerations involved with an investment in the securities of the Company and is qualified in its entirety by reference to the detailed information in the prospectus relating to its offering . Any decision to purchase the Company’s securities in any offering should be made solely on the basis of the information contained in the prospectus relating to its offering . Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this presentation . Any representation to the contrary is a criminal offense .
▪ Senior management team has a combined experience of over 50 years in consumer products with track record of innovation and execution in the vaping industry ▪ A well - known tobacco e - vaping brand in US and Europe, our brand Aspire e - vapor is sold in more than 30 countries ▪ As the pioneer of the vaporizer industry, Ispire’s management has a history of ground - breaking vaping technologies ▪ We own, will own or license a total of 200+ core technology patents issued across China, U.S., E.U. and etc. ▪ Capitalizing on proven success in products developments to expand our OEM/ODM business in tobacco ▪ Cannabis/CBD vaping total addressable market is projected at $9.6 billion in 2025 (1) ▪ Cannabis vaping – Fastest growing segment in the fast growing cannabis industry ▪ Favorable political environment anticipated based on the rise of popularity of cannabis ▪ The first vaping technology company listed in the U.S. stock market ▪ Driven by R&D leadership and history, Ispire provides innovative solutions to solve consumer pain points Highlights 1 st Vaping Company Listed in the US Large and Rapidly Growing Markets Industry Leading Innovations Globally Recognized Consumer Brand Deep B ench of I ndustry Ve terans 3 (1) Market study for Ispire by Euromonitor International Limited dated January 12,2022
Corporate Structure Ispire International Limited (British Virgin Islands) Aspire Science and Technology Limited (HK) Aspire North America LLC (California .U.S.) 100% 100% 100% Ispire Technology Inc. (Delaware. U.S.) » Ispire Technology Inc. (the Company) is incorporated in Delaware on June 13, 2022. » Aspire North America (product development, marketing and sales of cannabis vaping products) » Aspire Science and Technology (product development, marketing and sales of tobacco vaping products) 4
Company Overview Excellent R&D Capabilities +14 Years of experience ▪ Leverage over 14 years of experience in research and development of vaping products and quality control management of key personnel Extensive Distribution Network ( Tobacco products only) +200 Core patents ▪ Ispire will own or license over 200 utility/design patents which were received or filed globally by a related party +150 distributors ▪ Established network of reliable distributors with non - exclusive agreements for their respective sales regions +30 countries ▪ Globally recognized consumer brand with sales spanning across 30 countries Ispire is an innovative participant in the cannabis vaping industry Revenue Growth Highlights ▪ Revenue from cannabis products increased from $2.1 million to $20.0 m illion in fiscal 2022 (1) – first introduced in FY 2021 (1) ▪ Revenue from tobacco products experienced a stable YOY growth of 11% in the last fiscal year, achieved $68.1 m illion in FY22 (1) Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of our brande d v aping products Cannabis products: Marketed under “Ispire” brand name, primarily on an ODM basis, cannabis vaping hardware sales currently are only in the US Tobacco products: Marketed under “Aspire” brand name, sold primarily through distribution network worldwide (except for China, US and Russia) 5 61.3 68.1 2.1 20.0 0 20 40 60 80 FY21 FY22 Tabacco Products Cannabis Products Revenue by Products (in USD millions) 3% of Total Revenue 23% of Total Revenue (1) Our fiscal year ends June 30
History of Innovations (1) 1 2 3 4 202 3 2010 airflow adjustable tank Nautilus (Mini) 2013 2014 Sub - Ohm tank Atlantis 2015 tank without chimney Cleito series 4 4 4 2017 Hot selling pod system with auto - draw Breeze series 2018 Leak free and liquid Isolating technology Closed System 2020 Cannabis first dual coil vaporizer DuCore 2021 Single - use Cannabis vaporizer Disposable 2022 Cannabis vaporizer Daab 4 6 (1)The technology was developed by a related party, which is 95% owned by our CEO and which is our present supplier. Pursuan t t o agreements, the technology related to cannabis vaping products is being transferred to our wholly - owned subsidiary, and the technology relating to tobacco products is licensed to a wholly - owned indirect subsidiary. 4 202 3 Ispire One Self Sealing
Industry Pioneer in Cannabis Vaping Proprietary Technology Patented dual coil and airflow system technology enables users to create massive plumes of vape without burning the cannabis oil and eliminates the leakage of the oil from the unit, which we believe could provide the best - in - class airflow and taste Flexible OEM/ODM Solution Cartridge Collection Disposable Collection Battery Collection Leak - proof Design Multi - channel airflow design that prevents oil leakage by capturing oil in the inner chambers Stainless Steel & Pyrex Glass Food - grade stainless steel center - tube is highly resistant to rust as well as heat, enhancing safety and durability Dual Coils Patented Ducore technology and a leak - proof anti - clog body to ensure hassle - free performance Adjustable Airflow Control A fully customizable airflow system that allows you to easily adjust for the perfect hit every time Huge Airflow Delivery Airflow system that provides exceptional airflow that we believe is unrivaled by comparable products Connection Thread The connector makes Ducore cartridge compatible with most batteries on the market 7
Industry Leading Key Innovations x BDC (bottom dual coil) coil technology to provide much higher temperature and expanded heating that achieves much greater flavor and vapor production. U se of dual - coil technology enhances the flavor performance of e - liquid, and the hidden wick cotton with special designed wick holes can both extend the tank e - liquid capacity and improve the speed of wicking to increase the coil life. x BVC (bottom vertical coil) coil represents a big technological breakthrough with a vertical heating wire surrounded by the cotton. This design provide s uniform temperature from the tank, together with more efficient wicking. This new technology enables the coil to last longer while still giving users the purest and cleanest taste from e - liquids . x A new coil technology with the Cleito tank, which uses a revolutionary new coil design that replaces the standard chimney and delivers maximized airflow. This design frees up restriction in the airflow, resulting in an expanded flavor profile and increased vapor production. BDC (bottom dual coil) coil technology • Enhances the flavor performance of e - liquid ; Extends the tank e - liquid capacity ; Improves the speed of wicking to increase coil life BVC (bottom vertical coil) coil technology • Enables the coil to last longer while still giving users the purest and cleanest taste from e - liquids New coil technology with Cleito tank ( 1 ) • Frees up more restriction in the airflow, expands flavor profile and increases vapor production Technology and Innovation 8 (1)Currently only used for Tobacco devices
9 Cannabis Products x Sold directly by Ispire sales team in California, primarily on an ODM basis x All sales to date have been in the United States, commenced marketing efforts in Canada and Europe, primarily in the European Union Sales and Distribution Tobacco Vaping Products Sales Ratio By Region (dollars in thousands) Europe FY21: 71.8% FY22: 58.9% Asia Pacific （ exclude China) FY21: 18.8% FY22: 15.0% North America FY21: 9.3% FY22: 25.9% T obacco Products x Network of more than 150 distributors, covering over 30 countries x Distributors sell our products to wholesalers or directly to retail outlets and operate online channels such as Amazon Overall Sales Ratio By Region 38% + FY22 sales of tobacco products from largest distributer 76% + FY22 sales of tobacco products within Europe 99% FY22 sales of tobacco products from self - branded products 100% FY22 sales of cannabis products within the United States Europe , $45,568 - 74.4% Asia Pacific (excluding China) , $11,915 - 19.4% North America , $3,757 - 6.1% Other , $30 - 0.1% FY21 Europe , $51,886 - 76.2% Asia Pacific (excluding China) , $13,213 - 19.4% North America , $2,849 - 4.2% Other , $169 - 0.2% FY22
Cannabis Legalization in the U.S. Though cannabis is still a Schedule I drug under federal law, 19 states and District of Columbia (D.C.) have approved marijuana for recreational purposes, and 39 states for medicinal use Source: Wikipedia 1996 ▪ California became the first state to legalize medical cannabis 2014 ▪ Alaska, Oregon along with Washington D.C. legalized the recreation use of marijuana ▪ Indian Reservation legalization allowed 2016 ▪ Four more states are legalized, including California, Nevada, Massachusetts and Maine(first eastern states) 2012 ▪ Colorado and Washington became the first states to legalize recreation use of cannabis 2018 ▪ Vermont became the first state to legalize through an act of legislature 2020 ▪ The U.S. House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement Act (the "MORE Act") repealed convictions for nonviolent marijuana crimes, the first time one of the chamber of Congress has endorsed the legalization of marijuana 2022 Recent timeline of marijuana legalization ▪ In April, the U.S. House of Representatives passed the MORE Act that would legalize cannabis throughout the US. throughout ▪ In July, the U.S. Senate released the Cannabis Administration and Opportunity Act, the first draft of the federal legalization of marijuana ▪ In October, President Joe Biden issued an executive order pardoning all federal convictions for simple marijuana possession 10 Legal Legal for medical use Prohibited for any use D Notes : · Reflects law of states and territories, including laws which have not yet gone into effect. Does not reflect federal, tribal, or local laws. Decriminalized
3.1 4.7 6.5 8.7 13.0 20.0 27.0 33.0 38.8 43.8 48.3 0 10 20 30 40 50 2015 2016 2017 2018 2019 2020 2021 2022E 2023E 2024E 2025E Growth Potential for Cannabis Markets Projected US Cannabis Market 2015 – 2025E ( R etail V alue) (1) Market Size of Cannabis Vapor Products 2020 – 2025E (Retail Value) in USD billions 2021 - 2025E 2020 - 2021 21.4% 51.8% United States 21.7% 54.1% Global in USD billions 2.6 3.9 5.0 6.1 7.2 8.5 2.9 4.4 5.6 7.0 8.2 9.6 0 2 4 6 8 10 2020 2021 2022E 2023E 2024E 2025E United States Global 10.5 11.9 13.2 14.2 15.0 16.5 21.1 25.6 29.6 33.3 0 10 20 30 40 50 2021 2022E 2023E 2024E 2025E Medical Use Recreational Use Projected US Medical and Recreational Cannabis Sales 2021 – 2025E ( R etail V alue) (1) S . in USD billions (1)Source: The MJBiz Factbook/Euro Monitor 11 Projected CAGR of Cannabis Vapor Products Market Size
Global Recognized Tobacco Vaping Brand We are a well - known brand in Europe & US x Tobacco products are marketed and sold in over 30 countries x Our social media strategies aim to increase brand awareness; synergy across all platforms, including Instagram, Facebook and YouTube, following 21+ age verification guidelines x Through social media, we promote and educate on current and new products, as well as to provide real - time support to customers 12 Please confirm that the social media platforms mentioned are used by us rather than our distributors
Bench of Industry Veterans Tuanfang Liu | Co - CEO & Chairman ▪ Over 14 years of experience in research and development of the e - cigarette products and quality control management. ▪ Mr. Liu founded Shenzhen Yi Jia in 2010 and has served as its Chairman since then. ▪ Mr. Liu is responsible for daily operations and research and development of the e - cigarette and cannabis vaporizer technology products. ▪ Mr. Liu holds doctorate degrees in Business Management from Victoria University School of Management in Switzerland and EuroPort Business School in the Netherlands, respectively. Michael Wang | Co - CEO 13 ▪ 20+ years of experience as CEO, COO, and President. Approximately 12 years of internet technology and e - commerce experience. ▪ Mr. Wang served as the President, COO and Co - CEO of The Pharm/Sunday Goods (located in California and Arizona), a vertically integrated leader in the cannabis cultivation, processing, manufacturing, distribution, wholesale, and retail industry between 2018 to 2020. ▪ Mr. Wang received Bachelor of Science and Master of Science degrees in Aerospace Engineering in 1983 and 1985 respectively and received an MBA in Finance and General Management from the University of Chicago’s Booth School of Business in 1992.
Bench of Industry Veterans 14 Daniel Machock | Chief Financial Officer Tirdad Rouhani | Chief Operating Officer ▪ Mr. Machock has been the Chief Financial Officer since August 2023. Dan brings 25 years of experience overseeing the financial strategy and performance at a number of fast - growing companies. ▪ Mr. Machock was most recently CFO at Appetize Technologies, a point - of - sale hardware and software company. He has previously led successful teams at several other technology companies in Los Angeles including as CFO at Chrome River and PostSMSCo . ▪ Mr. Machock received his bachelor's degree in accounting and finance degrees from Indiana University and started his career in public accounting at Ernst and Young LLP in Chicago. ▪ Mr. Rouhani has been the Chief Operating Officer since July 2022 and held the role of Chief Operating Officer at Touchstone before taking on the role of Chief Executive Officer for Napalm Brands in March 2020. ▪ Mr. Rouhani co - founded two tech companies before converging on the cannabis industry. ▪ Mr. Rouhani received his undergraduate and graduate degrees from the University of Arizona.
Financial Overview 15
Questions & Answers Investor Relations & Media Contact Daniel Machock CFO Ispire Technologies Inc. ir@getispire.com 16